(Q46754805)

24 December 2017

title

Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study (English)

1 reference

24 December 2017

1 reference

3

Wakako Umene-Nakano

1 reference

24 December 2017

Reiji Yoshimura

1

Reiji Yoshimura

1 reference

24 December 2017

Jun Nakamura

7

Jun Nakamura

1 reference

24 December 2017

Atsuko Ikenouchi-Sugita

4

Atsuko Sugita

1 reference

24 December 2017

Nobuhisa Ueda

6

Nobuhisa Ueda

1 reference

24 December 2017

Hikaru Hori

5

Hikaru Hori

1 reference

24 December 2017

Shingo Kakihara

2

Shingo Kakihara

1 reference

24 December 2017

publication date

1 June 2008

1 reference

24 December 2017

published in

Human Psychopharmacology

1 reference

24 December 2017

volume

23

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

327-332

1 reference

24 December 2017

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

cites work

1 reference

Chart-recorded psychiatric diagnoses in women giving birth in California in 1992.

21 January 2018

1 reference

Effects of caffeine on behavior of schizophrenic inpatients.

21 January 2018

1 reference

Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues

21 January 2018

1 reference

Chronic psychiatric patients' use of caffeine: pharmacological effects and mechanisms

21 January 2018

1 reference

Clinically significant pharmacokinetic interactions between dietary caffeine and medications

21 January 2018

1 reference

7 January 2021

Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia

1 reference

7 January 2021

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

1 reference

7 January 2021

Nicotine intake in smokers increases following a single dose of haloperidol.

1 reference

7 January 2021

Effects of caffeine in chronic psychiatric patients

1 reference

7 January 2021

Does clozapine decrease smoking?

1 reference

7 January 2021

Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital

1 reference

7 January 2021

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia

1 reference

7 January 2021

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia

1 reference

7 January 2021

Adenosine-dopamine interactions in the brain

1 reference

7 January 2021

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

7 January 2021

Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.

1 reference

7 January 2021

Recent trends in smoking and the role of public policies: results from the SimSmoke tobacco control policy simulation model

1 reference

7 January 2021

Effects of the acute administration of caffeine in patients with schizophrenia.

1 reference

7 January 2021

Caffeine: use and effects in long-stay psychiatric patients

1 reference

7 January 2021

Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study

1 reference

7 January 2021

Clozapine decreases smoking in patients with chronic schizophrenia

1 reference

7 January 2021

Haloperidol increases smoking in patients with schizophrenia

1 reference

7 January 2021

Smoking and therapeutic response to clozapine in patients with schizophrenia

1 reference

7 January 2021

Smoking and movement disorders in psychiatric patients

1 reference

7 January 2021

Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients

1 reference

7 January 2021

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

7 January 2021

A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics

1 reference

7 January 2021

Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction

1 reference

7 January 2021

Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia

1 reference

7 January 2021

Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.928

1 reference

24 December 2017

1 reference

24 December 2017